Equity Capital Markets

Company · CIK 1971387

Liminatus Pharma, Inc.

CIK1971387 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressCA
ListedLIMN (Nasdaq), LIMNW (Nasdaq)
First annual or quarterly report2025-06-02

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-296986
Registered companyFiled
 2026-06-242026-06-241
333-293364
Registered companyFinal prospectus
 2026-02-112026-02-183
333-288289
Registered companyEffective
 2025-06-242025-08-123

Filings

11
FiledFilingRegistrationAccession
2026-06-24S-1Registration filed 333-2969860001104659-26-076958
2026-02-18424B4Final prospectus 333-2933640001104659-26-016706
2026-02-13EFFECTDeclared effective 333-2933649999999995-26-000587
2026-02-11S-1Registration filed 333-2933640001104659-26-012942
2025-12-31DRSDraft made public 377-089010001104659-25-125670
2025-08-12EFFECTDeclared effective 333-2882899999999995-25-002576
2025-07-28S-1/AAmendment 333-2882890001410578-25-001518
2025-06-24S-1Registration filed 333-2882890001410578-25-001432
2025-02-06EFFECTDeclared effective 333-2754099999999995-25-000331
2024-08-09EFFECTDeclared effective 333-2754099999999995-24-002472
2023-05-02DRSDraft made public 377-066960001104659-23-054602

All filings of this company · CSV